Clinical trials
PET clinical trials
Below are recruiting pet clinical trials, each written for real people, not researchers. We’re tracking 592 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05456503RecruitingPhase 3
PET scan study of tau buildup in memory and brain disorders
This Phase 3 study uses a PET/CT scan to measure whether a brain protein called tau (and related disease patterns) builds up in different dementia conditions. The goal is to better match which disorders have which brain changes and how they progress.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05501665RecruitingPhase 1/Phase 2
Adaptive radiation plus pembrolizumab for stage IV lung cancer
This trial tests a personalized (“adaptive”) radiation plan combined with pembrolizumab, and possibly chemotherapy, for advanced stage IV lung cancer. It aims to improve cancer control while carefully managing side effects, including in patients with certain brain metastases.
Nashville, TennesseeAges 18 years+ - NCT05512403RecruitingPhase 3
Test of FDOPA PET scan to evaluate a brain tumor
This study checks how well an FDOPA PET scan can identify and describe a specific type of brain tumor at the beginning. Results may help doctors decide on the best next steps for diagnosis and treatment planning.
Vandœuvre-lès-NancyAges 18–75 - NCT05516719Recruiting
Study tracking I2BS in Parkinson’s over time
This study follows people with Parkinson’s to see how “I2BS” changes over time using special brain scans and other tests. It may help researchers better understand Parkinson’s and improve how it’s measured in future trials.
Exeter, DevonAges 25 years+ - NCT05518617Recruiting
Imaging study for inherited Parkinson’s using PET, SPECT, and spinal fluid
This trial tests how well special brain scans (PET/SPECT) and spinal fluid tests can show changes in people with inherited (genetic) Parkinson’s. It may help researchers understand what’s happening in the brain and improve how these conditions are measured.
Exeter, DevonAges 25–80 - NCT05554302RecruitingPhase 2
PET scan study for brain metastases after surgery
This trial studies how well a special PET scan tracer (18F-fluciclovine) shows amino-acid changes in brain metastases after they are surgically removed. It may help improve how doctors detect and understand brain metastases and guide follow-up treatment like targeted radiation (SRS).
Miami, FloridaAges 18 years+ - NCT05555550RecruitingEarly Phase 1
PET-MRI scan to study low-grade brain tumors in children
This early-phase study tests how well a special PET-MRI scan (using a radioactive tracer) can find and measure low-grade brain tumors. It may help doctors better track these tumors while you start or continue treatment.
Philadelphia, PennsylvaniaAges 1–21 - NCT05562791RecruitingPhase 1
Testing PSMA PET/CT scans for metastatic bladder or skin cancer
This Phase 1 study tests how well a PSMA PET/CT scan can find cancer spots in people with metastatic bladder cancer (urothelial cancer) or metastatic melanoma. It may help doctors better see where cancer is and guide next steps.
Basking Ridge, New JerseyAges 18 years+ - NCT05577598Recruiting
Brain scan study of deep brain stimulation in OCD
This trial uses a special PET scan to see how brain sugar use changes during deep brain stimulation for obsessive-compulsive disorder (OCD). It may help researchers understand what brain activity patterns relate to treatment response.
Vienna, State of ViennaAges 18–75 - NCT05582876Recruiting
PET/MR scan to plan personalized prostate cancer treatment
This study uses a special scan called PET/MR with a prostate-focused tracer to help doctors choose the best next treatment for prostate cancer. It may be most helpful if you are planning major treatment or if your cancer has come back after prior treatment.
BialystokAges 18–99 - NCT05583721RecruitingPhase 2
PET scan study of heart filling and blood flow in sickle cell
This study uses a PET scan to look for links between abnormal heart “filling” problems and how well blood reaches the heart muscle in people with sickle cell disease. The results may help explain early heart changes in sickle cell and guide future care.
Memphis, TennesseeAges 18–21 - NCT05614310Recruiting
Brain scan study to spot early Alzheimer’s
This study uses MRI brain scans and memory tests to help detect early Alzheimer’s disease. It compares people with Alzheimer’s (diagnosed by a clinician) with people without memory problems to see which scan and test results stand out.
AberdeenAges 18 years+ - NCT05629689RecruitingPhase 1
PET scan drug check for people with solid tumors
This Phase 1 study tests whether an investigational PET scan tracer is safe and tolerable when used for PET imaging in people with certain solid cancers. It mainly looks at side effects and how well the scan can be done, not whether it treats cancer.
AmsterdamAges 18 years+ - NCT05630963Recruiting
Study sleep-like brain signaling in major depression
This trial looks at how a specific brain receptor related to pain signals (nociceptin/orphanin FQ receptor) may be involved in depression. It may help researchers understand depression better by comparing people with current versus past (remitted) major depression.
Belmont, MassachusettsAges 18–45 - NCT05636748Recruiting
Study how blood clots affect stroke, using special scans
This study looks at how blood clots form and contribute to an acute ischemic (clot-related) stroke. It uses PET-CT scanning to better understand the process and may help improve how future stroke treatments are targeted.
EdinburghAges 18 years+ - NCT05653635RecruitingPhase 2
PET-DOPA to guide repeat radiation for glioblastoma recurrence
This Phase 2 study tests whether a special brain scan called PET-DOPA can help guide repeat radiation for glioblastoma that has come back. It aims to improve treatment planning while keeping tumors within safe radiation limits near important brain structures.
Nancy, DeAges 18 years+ - NCT05654675Recruiting
Scan method study for measuring tumor sugar use on PET
This study checks whether a specific analysis method (called FUR) can better measure how much “sugar” from PET scans is used by tumors. It uses regular PET/CT scans you may already get as part of standard care, and compares how the measurements work.
Maastricht, LimburgAges 18 years+ - NCT05681858Recruiting
Testing heart inflammation and reduced blood flow in MINOCA
This study looks at why some people have chest pain and heart injury signs, but their heart arteries are not blocked. It tests scans of blood flow and heart tissue to better understand the cause and guide care.
BergenAges 18 years+ - NCT05741151Recruiting
Testing a nerve target in Parkinson’s disease
This trial is studying the “superior cervical ganglion” as a possible treatment approach for Parkinson’s disease. It may help people whose symptoms are truly caused by Parkinson’s, not by another condition.
RomeAges 30–80 - NCT05745961Recruiting
Measuring a lung protein in pulmonary artery hypertension
This study measures how much of a specific lung protein (TSPO) is present in people with pulmonary artery hypertension. The results may help researchers better understand the disease and guide future treatments.
LondonAges 25–75 - NCT05761366RecruitingPhase 2
18F-PSMA PET/CT scan for PSMA-positive tumors
This Phase 2 study tests an imaging scan called 18F-PSMA PET/CT to find tumors that have a specific marker (PSMA). It may help doctors better locate and evaluate PSMA-positive cancers.
Beijing, ChaoyangAges 18 years+ - NCT05776212Recruiting
Imaging study for certain heart amyloidosis types and heart thickening
This trial uses special heart imaging to better measure how amyloid deposits affect the heart in people with certain diagnoses. The goal is to understand which imaging signals match your disease and to see if this approach could help guide care.
GroningenAges 40 years+ - NCT05793008Recruiting
Studying heart stress syndrome in sepsis using heart scans
This study looks at Takotsubo (also called stress cardiomyopathy) and heart problems caused by sepsis using specialized heart imaging (including PET). The goal is to better understand what triggers these conditions and how the heart is affected, which may improve diagnosis and care.
RomeAges 18 years+ - NCT05806515RecruitingPhase 2
Carboplatin before surgery for high-risk BRCA prostate cancer
This trial tests giving the chemotherapy drug carboplatin before surgery to treat people with high-risk prostate cancer and an inherited BRCA1 or BRCA2 gene change. The goal is to shrink or control the cancer before an operation and improve outcomes.
Anchorage, AlaskaAges 18 years+
Hear when a new PET trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pet?
- Yes. Clin2 currently lists 592 recruiting pet studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pet trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pet trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.